アムゲンは四半期の収入が強いと報告し,EPSは24%上昇し,収入は一年に9.4%増加した. Amgen reports strong quarterly earnings, with EPS up 24% and revenue increasing 9.4% year-over-year.

Kwmg LLCは生物医薬品会社アムゲン社で,88%の保有率で,6.18億円に評価される1万9,835株の株式を保有している. Institutional investor Kwmg LLC increased its holdings in biopharmaceutical company Amgen Inc. by 1.8%, owning 19,835 shares valued at $6.18 million. アムゲンは,昨年3.96ドルから4.90ドル,8.15億円の収益,年比9.4パーセントの増加を報告した. Amgen reported a strong quarter with an EPS of $4.90, up from $3.96 last year, and revenue of $8.15 billion, a 9.4% increase year-over-year. 株式は288.47ドルで開店し,市場キャピタルは155.11億ドルです. The company’s stock, which opened at $288.47, has a market cap of $155.11 billion. 分析官は複雑な視点を持ち,平均評価は"ホールド"で,目標価格は3909.22. Analysts have a mixed outlook, with an average rating of "hold" and a target price of $309.22. アムゲン の 製品 は , 嚢胞 , 関節 炎 , 複数 の メラマ など の 症状 を 治療 し ます。 Amgen’s products treat conditions including psoriasis, arthritis, and multiple myeloma.